InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Lamstein Joshua R, Président. Insider active across 1 companies, notably Scopus BioPharma Inc.. Aggregated, 6 filings have been logged. Total volume traded: €19k. The latest transaction was filed on 26 August 2021 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
€834200 shares@ €4.16798.7% of flow
Common Stock, par value $0.001
SEC:0001104659-21-110652·
Ideal exit: 23 May 2022 (T+270)
€834200 shares@ €4.16793.30% mcap4.3% of flow
Common Stock, par value $0.001
SEC:0001104659-21-110652:0·
Ideal exit: 23 May 2022 (T+270)
€2,768800 shares@ €3.459928.8% of flow
Common Stock, par value $0.001
SEC:0001104659-21-108657·
Ideal exit: 16 May 2022 (T+270)
€2,768800 shares@ €3.459910.96% mcap14.4% of flow
Common Stock, par value $0.001
SEC:0001104659-21-108657:0·
Ideal exit: 16 May 2022 (T+270)
€6,0011,500 shares@ €4.000862.5% of flow
Common Stock, par value $0.001
SEC:0001104659-21-096342·
Ideal exit: 19 Apr 2022 (T+270)
€6,0011,500 shares@ €4.000823.77% mcap31.2% of flow
Common Stock, par value $0.001
SEC:0001104659-21-096342:0·
Ideal exit: 19 Apr 2022 (T+270)
6 of 6 declarations
About Lamstein Joshua R
Joshua R. Lamstein serves as Chairman of Scopus BioPharma Inc. In this role, he oversees the activities of the board of directors and contributes to the strategic direction of the company. Joshua brings valuable experience in the biopharmaceutical sector, enabling him to assess growth and innovation opportunities. His role is crucial in ensuring compliance and transparency in governance.
